|
Volumn 82, Issue 1, 2004, Pages 77-78
|
WHO hopes 3-by-5 plan will reverse Africa's HIV/AIDS epidemic.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
LAMIVUDINE;
NEVIRAPINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
STAVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
AFRICA;
ARTICLE;
CHILD;
DEVELOPING COUNTRY;
DRUG COMBINATION;
ECONOMICS;
EPIDEMIC;
FEMALE;
FOSTER CARE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
UNITED NATIONS;
WORLD HEALTH ORGANIZATION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADULT;
AFRICA;
ANTI-HIV AGENTS;
CHILD;
DEVELOPING COUNTRIES;
DISEASE OUTBREAKS;
DRUG COMBINATIONS;
FEMALE;
FOSTER HOME CARE;
HIV INFECTIONS;
HUMANS;
LAMIVUDINE;
MALE;
NEVIRAPINE;
REVERSE TRANSCRIPTASE INHIBITORS;
STAVUDINE;
UNITED NATIONS;
WORLD HEALTH ORGANIZATION;
|
EID: 2342463612
PISSN: 00429686
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|